IL-6 is also increased in the bronchoalveolar lavage (BAL) fluid of patients with ARDS and high levels are associated with adverse outcomes [25], [26]; thus, IL-6 may contribute to lung injury via direct effects in the alveolar space. The gene discussed is IL6; the disease is acute respiratory distress syndrome.